Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


International Bioprinting Congress

24 Jul 2014 - 25 Jul 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is pleased to present the inaugural International Bioprinting Congress, which will take place at the Biopolis, Singapore.

The event will present the leading international scientists and thought leaders within this rapidly developing field. Featuring Professor Chua Chee Kai, Chair, School of Mechanical and Aerospace Engineering, Nanyang Technological University and Director Nanyang Additive Manufacturing Centre, Singapore and Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan as our conference chairs. This event will provide you with a detailed insight into the latest developments and techniques in 3D bioprinting.

During this conference, you will learn about the many advances in 3D bioprinting covering; Additive Manufacturing of Tissues and Biofabrication, Scaffolds and Biomaterials for Tissue Engineering, Biological Laser Printing, Biological Inkjet Printing, Search for the Synergy by Fusion of Bio-Additive Manufacturing and Micro Manufacturing, Cell and Tissue Patterning for Lab-on-a-Chip and Tissue Models plus Additive Manufacturing and Medical Devices.
Scientific presentations will be followed by panel discussions on the day’s topics, providing
a balanced overview of the industry from the varied perspectives of the leading researchers, investors and legislative authorities.

Scientific presentations will be followed by panel discussions on the day’s topics, providing
a balanced overview of the industry from the varied perspectives of the leading researchers, investors and legislative authorities.

A tour of the facilities at the Nanyang Technological University Additive Manufacturing Centre will also be offered. The tour is open to all conference attendees and will take place on Thursday 24th July, with coach transfers leaving the Biopolis at 16:00.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations.



Further information
Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!